Xconomy

DECEMBER 5, 2017

Author, investor, and AOL co-founder Steve Case today announced a new $150 million venture fund aimed at pumping investment capital into tech companies in so-called flyover states. Contributing to the fund is an impressive group of some of the most successful entrepreneurs in the country.

Seed Funding 45

Seed Funding Funding Venture Capital Startup 45

Both Sides of the Table

SEPTEMBER 28, 2014

I was reading Danielle Morrill’s blog post today on whether one’s “ Startup Burn Rate is Normal. by Michael Woolf that is worth any startup founder reading to get a sense of perspective on the reality warp that is startup world during a frothy market such as 1997-1999, 2005-2007 or 2012-2014. Profitability.

Startup 383

Startup Company Companies .Net 383

Both Sides of the Table

OCTOBER 26, 2014

The best case I’ve seen is our portfolio company Osmo who had already built the product but used crowd-funding to handle inventory management, supply-chain logistics and perfecting the final version of the product. Contrary to popular opinion I actually believe crowd-funding is best used after seed capital or venture capital.

Press 319

Press Startup Writing Training 319

Xconomy

JULY 26, 2017

Illumina (NASDAQ: ILMN ), a San Diego-based company that was a pioneer in gene sequencing technology, founded the accelerator in 2014, along with Russian billionaire Yuri Milner. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Startup 79

Startup San Diego Class Capital 79

TechCrunch LA

NOVEMBER 4, 2019

First it was street-style photography, then came the launch of her popular fashion blog WeWoreWhat. Bain Capital Ventures' Jamison Hill. The startup has already secured a seed investment from Maveron and CRV, TechCrunch has learned, and will receive another $150,000 in exchange for 7% equity upon entering YC next year.

Platform 170

Platform Marketing Tool Venture Capital 170

Xconomy

JUNE 3, 2016

Merck also saw some expected fruits of its 2014 big-ticket acquisition of Cubist Pharmaceuticals wither away this week, as the Supreme Court wouldn’t reverse a decision that shaved years off the patent life of the top-selling antibiotic daptomyicin (Cubicin). —When Merck (NYSE: MRK ) bought Cubist Pharmaceuticals for $9.5

San Diego 62

San Diego Patents Acquisition News 62

Both Sides of the Table

OCTOBER 18, 2015

There is a lot of uncertainty about the state of the private, high-growth technology markets and the venture capital markets that underpin them. Technology riches yield bumper crops in venture capital with new firms and new largesses – the rewards of LPs rediscovering our asset class. Are LPs to blame?

Venture Capital 150

Venture Capital Pricing Platform Marketing 150